20 related articles for article (PubMed ID: 2505522)
1. Routine MR Imaging Protocol and Standardization in Central Nervous System Demyelinating Diseases.
Traboulsee A; Li DKB
Neuroimaging Clin N Am; 2024 Aug; 34(3):317-334. PubMed ID: 38942519
[TBL] [Abstract][Full Text] [Related]
2. Decoding unusual MR findings: Spinal cord edema in atypical cervical spondylotic myelopathy-A case report and literature review.
Zhu Q; Wang D
Clin Case Rep; 2023 Dec; 11(12):e8261. PubMed ID: 38125624
[TBL] [Abstract][Full Text] [Related]
3. MRI in acute transverse myelopathy.
Holtås S; Basibüyük N; Fredriksson K
Neuroradiology; 1993; 35(3):221-6. PubMed ID: 8459927
[TBL] [Abstract][Full Text] [Related]
4. Gadolinium-enhanced magnetic resonance imaging of the central nervous system in systemic lupus erythematosus.
Miller DH; Buchanan N; Barker G; Morrissey SP; Kendall BE; Rudge P; Khamashta M; Hughes GR; McDonald WI
J Neurol; 1992 Oct; 239(8):460-4. PubMed ID: 1447575
[TBL] [Abstract][Full Text] [Related]
5. Gd-DTPA-enhanced MR imaging of injured spinal cord.
Terae S; Takahashi C; Abe S; Kikuchi Y; Miyasaka K
Clin Imaging; 1997; 21(2):82-9. PubMed ID: 9095382
[TBL] [Abstract][Full Text] [Related]
6. Acute transverse myelopathy: spinal and cranial MR study with clinical follow-up.
Campi A; Filippi M; Comi G; Martinelli V; Baratti C; Rovaris M; Scotti G
AJNR Am J Neuroradiol; 1995 Jan; 16(1):115-23. PubMed ID: 7900579
[TBL] [Abstract][Full Text] [Related]
7. Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis.
Bastianello S; Pozzilli C; Bernardi S; Bozzao L; Fantozzi LM; Buttinelli C; Fieschi C
Neurology; 1990 Apr; 40(4):591-5. PubMed ID: 2320230
[TBL] [Abstract][Full Text] [Related]
8. Gd-enhanced MR imaging of acute and chronic experimental demyelinating lesions.
Kuharik MA; Edwards MK; Farlow MR; Becker GJ; Azzarelli B; Klatte EC; Augustyn GT; Dreesen RG
AJNR Am J Neuroradiol; 1988; 9(4):643-8. PubMed ID: 3135711
[TBL] [Abstract][Full Text] [Related]
9. Multicenter double-blind placebo-controlled study of gadopentetate dimeglumine as an MR contrast agent: evaluation in patients with cerebral lesions.
Russell EJ; Schaible TF; Dillon W; Drayer B; LiPuma J; Mancuso A; Maravilla K; Goldstein HA
AJR Am J Roentgenol; 1989 Apr; 152(4):813-23. PubMed ID: 2646872
[TBL] [Abstract][Full Text] [Related]
10. MR contrast enhancement of intracranial lesions with Gd-DTPA.
Hesselink JR; Press GA
Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
[TBL] [Abstract][Full Text] [Related]
11. Gd-DTPA-enhanced MR of suspected spinal multiple sclerosis.
Larsson EM; Holtås S; Nilsson O
AJNR Am J Neuroradiol; 1989; 10(5):1071-6. PubMed ID: 2505522
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
